Health
Scientists Identify Potential Drug Candidate Against Covid-19, Stops Virus from Replicating in Host Cells – News18
Ebselen, a chemical compound with anti-viral, anti-inflammatory, anti-oxidative, bactericidal and cell-protective properties, is used to treat bipolar disorder and loss of hearing.
Using state-of-the-art computer simulations, scientists have identified a preexisting drug, used to treat multiple diseases, including bipolar disorders and hearing loss, that could prevent the novel coronavirus from replicating in host cells, an advance that may lead to a therapeutic solution against COVID-19. The study, published in the journal Science Advances, assessed the molecule main protease, Mpro, of the novel coronavirus which is a key enzyme that plays a central role in its life cycle…
-
General22 hours agoQueensland government strikes new deal with Bravus to defer royalties, expand Carmichael coal mine
-
Noosa News21 hours agoFamily’s heartbreak after Trevor Doyle found dead in park in Logan
-
General21 hours agoTwo men involved in fatal helicopter accident charged over stealing crocodile eggs from Kakadu National Park
-
Business24 hours agoMacquarie predicts more than 40% upside for this ASX 200 stock